Innovating Works

MpoxVax AFRIVAC

financed
Expanding a prospective clinical trial examining the immune response of partici...
Expanding a prospective clinical trial examining the immune response of participants receiving Modified Vaccinia Ankara vaccine to Africa. The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and over 1,000 deaths, with women accounting for more than half of those affected. The previous... see more
31/03/2027
unknown leader
1M€
Project Budget: 1M€

Project leader unknown leader
PARTICIPATION DEPralty Sin fecha límite de participación.
Financing granted El organismo HORIZON EUROPE notifico la concesión del proyecto The day 2024-10-03
HORIZON-JU-GH-EDCTP3-2024-Mpox: Mobilisation of Emergency funding f... Expected Outcome:This topic aims at supporting activities that contribute to answering the most pres...
Cerrada does 1 year
0% 100% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.